Diversified Enterprises’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Diversified Enterprises’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$501K	Hold	4,066	–	–	0.02%	274
2026 Q2	$482K	Buy	4,066 +1	+0%	+$108	0.02%	255
2026 Q1	$422K	Buy	4,065 +2	+0%	+$211	0.02%	269
2025 Q4	$425K	Buy	4,063 +2	+0%	+$201	0.03%	237
2025 Q3	$376K	Buy	4,061 +2	+0%	+$175	0.03%	202
2025 Q2	$324K	Buy	4,059 +2	+0%	+$160	0.02%	214
2025 Q1	$351K	Buy	4,057 +2	+0%	+$170	0.03%	202
2024 Q4	$335K	Buy	4,055 +2	+0%	+$172	0.03%	170
2024 Q3	$353K	Buy	+4,053	New	+$347K	0.04%	161

Other funds holding PJP

Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return

Outlook Wealth Advisors Shenandoah, Texas $470M AUM 20.06% 1-Year Est. Return

Dumont & Blake Investment Advisors Princeton, New Jersey $398M AUM 22.72% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

Diversified Enterprises's PJP Position: Q3 2026 in Review

Diversified Enterprises held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 4,066 shares worth $501K. The position accounts for 0.02% of the portfolio, ranked #274.

Diversified Enterprises first reported a position in PJP in Q3 2024 and has held it in 9 quarters since. 37 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

Diversified Enterprises held 4,066 shares of Invesco Pharmaceuticals ETF worth $501K as of Q3 2026.
Diversified Enterprises left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
Invesco Pharmaceuticals ETF made up 0.02% of Diversified Enterprises's portfolio in Q3 2026, its #274 holding.
Diversified Enterprises first reported a position in Invesco Pharmaceuticals ETF in Q3 2024 and has held it in 9 quarters since.
37 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.